Epigenetic regulation of the endothelial nitric oxide synthase gene in persistent pulmonary hypertension of the newborn rat

被引:72
|
作者
Xu, Xue-Feng [1 ]
Ma, Xiao-Lu [1 ]
Shen, Zheng [1 ]
Wu, Xi-Ling [1 ]
Cheng, Fen [1 ]
Du, Li-Zhong [1 ]
机构
[1] Zhejiang Univ, Sch Med, Childrens Hosp, Hangzhou 310003, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
endothelial nitric oxide synthase; endothelium; epigenetics; persistent pulmonary hypertension of the newborn; HISTONE H3 MODIFICATIONS; DNA METHYLATION; LUNG DEVELOPMENT; ADULT DISEASE; EXPRESSION; CELLS; FETAL; ORIGINS; ETHANOL; ACETYLATION;
D O I
10.1097/HJH.0b013e32833e08f1
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective Persistent pulmonary hypertension of the newborn (PPHN) is a major clinical problem. Nitric oxide produced by endothelial nitric oxide synthase (eNOS) in endothelial cells plays an important role in the pathogenesis of PPHN. The eNOS expression in endothelial cells is controlled by epigenetic regulation. The aim of this study was to investigate the epigenetic regulatory mechanisms of the eNOS gene in PPHN. Methods The rat model of PPHN was induced by hypoxia and indomethacin. Pulmonary vascular endothelial cells were isolated from the fetal rat lungs by magnetic-activated cell sorting. Chromatin immunoprecipitation and bisulfite sequencing methods were used to analyze epigenetic regulation. Results The levels of acetylated histone H3 and acetylated histone H4 at the proximal promoter of the eNOS gene in pulmonary vascular endothelial cells from PPHN were significantly higher than those from the control group (P < 0.01, respectively). Total methylation percentage of the eNOS gene promoter in PPHN rat was slightly lower than that of control, but there was no statistically significant difference between the two groups (24.7 +/- 2.0 vs. 27.3 +/- 2.3%, P = 0.408). These changes of epigenetic modifications at the eNOS gene promoter were consistent with increased levels of eNOS mRNA and protein in PPHN. Conclusion The increased expression of eNOS in PPHN was associated with epigenetic regulation. J Hypertens 28: 2227-2235 (C) 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins.
引用
收藏
页码:2227 / 2235
页数:9
相关论文
共 50 条
  • [31] Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn
    Davidson, D
    Barefield, ES
    Kattwinkel, J
    Dudell, G
    Damask, M
    Straube, R
    Rhines, J
    Chang, CT
    PEDIATRICS, 1999, 104 (02) : 231 - 236
  • [32] INHALATIONAL NITRIC-OXIDE THERAPY FOR PERSISTENT PULMONARY-HYPERTENSION OF THE NEWBORN
    KINSELLA, JP
    ABMAN, SH
    PEDIATRICS, 1993, 91 (05) : 997 - 998
  • [33] Endogenous nitric oxide and endothelin-1 in persistent pulmonary hypertension of the newborn
    Akihiko Endo
    M. Ayusawa
    M. Minato
    M. Takada
    S. Takahashi
    K. Harada
    European Journal of Pediatrics, 2001, 160 : 217 - 222
  • [34] Association of endothelial nitric-oxide synthase gene polymorphism with hypertension
    Jáchymová, M
    Horky, K
    Jindra, A
    Bultas, J
    Peleska, J
    Umnerová, V
    Marecková, Z
    Heller, S
    Martásek, P
    Kozich, V
    JOURNAL OF HYPERTENSION, 2000, 18 : S147 - S147
  • [35] HYPERTENSION IN MICE LACKING THE GENE FOR ENDOTHELIAL NITRIC-OXIDE SYNTHASE
    HUANG, PL
    HUANG, ZH
    MASHIMO, H
    BLOCH, KD
    MOSKOWITZ, MA
    BEVAN, JA
    FISHMAN, MC
    NATURE, 1995, 377 (6546) : 239 - 242
  • [36] Lack of linkage between the endothelial nitric oxide synthase gene and hypertension
    Hunt, SC
    Williams, CS
    Sharma, AM
    Inoue, I
    Williams, RR
    Lalouel, JM
    JOURNAL OF HUMAN HYPERTENSION, 1996, 10 (01) : 27 - 30
  • [37] Endothelial nitric oxide synthase gene is positively associated with essential hypertension
    Miyamoto, Y
    Saito, Y
    Kajiyama, N
    Yoshimura, M
    Shimasaki, Y
    Nakayama, M
    Kamitani, S
    Harada, M
    Ishikawa, M
    Kuwahara, K
    Ogawa, E
    Hamanaka, I
    Takahashi, N
    Kaneshige, T
    Teraoka, H
    Akamizu, T
    Azuma, N
    Yoshimasa, Y
    Yoshimasa, T
    Itoh, H
    Masuda, I
    Yasue, H
    Nakao, K
    HYPERTENSION, 1998, 32 (01) : 3 - 8
  • [38] Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene
    Steudel, W
    Ichinose, F
    Huang, PL
    Hurford, WE
    Jones, RC
    Bevan, JA
    Fishman, MC
    Zapol, WM
    CIRCULATION RESEARCH, 1997, 81 (01) : 34 - 41
  • [39] Gene transfer of endothelial nitric oxide synthase attenuates flow-induced pulmonary hypertension in rabbits
    Zhang, Fengwei
    Wu, Shuming
    Lu, Xianshuo
    Wang, Mo
    Liu, Meiming
    ANNALS OF THORACIC SURGERY, 2008, 85 (02): : 581 - 586
  • [40] Is inhaled nitric oxide a miraculous molecule? The analysis of nitric oxide use in newborns with persistent pulmonary hypertension of the newborn
    Srnkova, Patricia
    Brucknerova, Jana
    Brucknerova, Ingrid
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2022, 123 (03): : 153 - 159